Vor Biopharma (VOR) Profit After Tax (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Profit After Tax data on file, last reported at -$219.6 million in Q1 2026.

• Profit After Tax for Q1 2026 came in at -$219.6 million, down 575.94% year-over-year; the trailing twelve-month figure through Mar 2026 was -$883.1 million (down 644.61% YoY), and the FY2025 annual result was -$696.0 million, down 495.29% from the prior year.
• Profit After Tax fell to -$219.6 million in Q1 2026 per VOR's latest filing, from $1.7 billion in the prior quarter.
• Over five years, Profit After Tax peaked at $1.7 billion in Q4 2025 and troughed at -$1.6 billion in Q2 2025.
• A 5-year average of -$73.1 million and a median of -$28.4 million in 2023 frame the typical range for Profit After Tax.
• On a YoY basis, Profit After Tax climbed as much as 5709.72% in 2025 and fell as far as 5552.75% in 2025.
• A 5-year view of Profit After Tax shows it stood at -$23.9 million in 2022, then fell by 9.83% to -$26.3 million in 2023, then decreased by 16.95% to -$30.7 million in 2024, then jumped by 5709.72% to $1.7 billion in 2025, then sank by 112.75% to -$219.6 million in 2026.
• Business Quant data shows VOR's Profit After Tax at -$219.6 million in Q1 2026, $1.7 billion in Q4 2025, and -$812.7 million in Q3 2025.